Education
About Us
Working with TipRanks
Follow Us
Vor Biopharma (VOR)
NASDAQ:VOR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -3.49M | $ -8.96M | $ 0.00 | $ 0.00 |
| Operating Income | $ -121.19M | $ -126.04M | $ -93.42M | $ -69.02M | $ -43.37M |
| EBITDA | $ -117.66M | $ -114.37M | $ -83.13M | $ -67.58M | $ -42.76M |
| Net Income | $ -116.91M | $ -117.86M | $ -92.09M | $ -68.90M | $ -43.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 91.93M | $ 137.18M | $ 230.25M | $ 207.47M | $ 48.54M |
| Total Assets | $ 142.89M | $ 209.83M | $ 299.37M | $ 242.59M | $ 75.91M |
| Total Debt | $ 31.83M | $ 35.66M | $ 38.91M | $ 18.01M | $ 18.29M |
| Net Debt | $ -50.12M | $ 4.30M | $ -18.79M | $ -101.79M | $ -30.25M |
| Total Liabilities | $ 46.23M | $ 59.10M | $ 48.76M | $ 26.33M | $ 27.64M |
| Stockholders' Equity | $ 96.66M | $ 150.72M | $ 250.61M | $ 216.26M | $ 48.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -99.89M | $ -101.36M | $ -93.61M | $ -73.04M | $ -40.45M |
| Operating Cash Flow | $ -99.66M | $ -100.29M | $ -85.14M | $ -69.14M | $ -36.29M |
| Investing Cash Flow | $ 96.86M | $ 71.01M | $ -94.09M | $ -91.65M | $ -4.16M |
| Financing Cash Flow | $ 53.39M | $ 2.94M | $ 117.14M | $ 232.91M | $ 82.53M |